Detalhe da pesquisa
1.
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models.
Gastric Cancer
; 27(3): 473-483, 2024 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38261067
2.
Personalized therapeutic strategies in HER2-driven gastric cancer.
Gastric Cancer
; 24(4): 897-912, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33755862
3.
Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair.
Clin Cancer Res
; 30(10): 2193-2205, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38592373
4.
Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations.
Sci Adv
; 10(11): eadh4435, 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38489371
5.
Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signaling.
Blood
; 117(2): 419-28, 2011 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-20585044
6.
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer.
Cell Oncol (Dordr)
; 46(3): 661-676, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36753044
7.
HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial.
Clin Cancer Res
; 29(3): 571-580, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36413222
8.
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
Cancer Res
; 83(10): 1699-1710, 2023 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37129948
9.
The importance of being CAFs (in cancer resistance to targeted therapies).
J Exp Clin Cancer Res
; 41(1): 319, 2022 Nov 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36324182
10.
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
J Exp Clin Cancer Res
; 41(1): 112, 2022 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35351166
11.
A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer.
Transl Oncol
; 15(1): 101260, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34735897
12.
The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth.
J Biol Chem
; 285(50): 38756-64, 2010 Dec 10.
Artigo
Inglês
| MEDLINE | ID: mdl-20937830
13.
The semaphorin 4D receptor controls invasive growth by coupling with Met.
Nat Cell Biol
; 4(9): 720-4, 2002 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-12198496
14.
Hepatocyte growth factor and its receptor are required for malaria infection.
Nat Med
; 9(11): 1363-9, 2003 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-14556002
15.
Microsatellite instability in Gastric Cancer: Between lights and shadows.
Cancer Treat Rev
; 95: 102175, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33721595
16.
Molecularly Targeted Therapies for Gastric Cancer. State of the Art.
Cancers (Basel)
; 13(16)2021 Aug 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34439248
17.
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas.
Clin Cancer Res
; 27(11): 3126-3140, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33542076
18.
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.
Mol Cancer
; 9: 121, 2010 May 26.
Artigo
Inglês
| MEDLINE | ID: mdl-20500904
19.
Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells.
Cancers (Basel)
; 12(8)2020 Aug 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32784465
20.
Patient-Derived Cancer Models.
Cancers (Basel)
; 12(12)2020 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33333972